Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H29NO4 |
Molecular Weight | 395.4914 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)COCCOCCN1CCC(CC1)=C(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=KMUBBNQZNBTUSH-UHFFFAOYSA-N
InChI=1S/C24H29NO4/c26-23(27)19-29-18-17-28-16-15-25-13-11-22(12-14-25)24(20-7-3-1-4-8-20)21-9-5-2-6-10-21/h1-10H,11-19H2,(H,26,27)
Molecular Formula | C24H29NO4 |
Molecular Weight | 395.4914 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Pibaxizine is diphenylmethyl piperazine derivatives. It is a histamine H1 receptor antagonist. Animal experiments have shown that it has spasmolytic properties for smooth muscle, particularly in the bronchi, as well as anticholinergic and anti-serotonin activities. It can be concluded that Pibaxizine has a strong protective effect against bronchospasm caused by inhalation of a histamine aerosol. Protection against methacholine-induced bronchospasm was less marked. Pibaxizine had been in phase II clinical trial for the treatment of chronic obstructive pulmonary disease. However, this development was discontinued.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0006939 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3899673 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:35:26 GMT 2023
by
admin
on
Fri Dec 15 15:35:26 GMT 2023
|
Record UNII |
224TL37A39
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
133875
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
6525
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
224TL37A39
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
DTXSID701002573
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
SUB09802MIG
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105247
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
82227-39-2
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
100000082469
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
C74272
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |